Trends and future projections of cancer prevalence in patients with cardiovascular admissions
The prevalence of cancer among patients hospitalized with CV disease is predicted to increase 2.48-fold by 2040. This trend highlights the importance of integrated cardio-oncology and multidisciplinary care models.
Authors
- Asher Elad
- Evangelos Kontopantelis (ORCID: https://orcid.org/0000-0001-6450-5815)
- Carmen Moldovan
- Z Raisi-Estabragh
- C H R I S T Mallen
- Mamas A Mamas
- Andrija Matetic
- Guia Ferrari Ardicini
Institutions
- Vita-Salute San Raffaele University (IT)
- National University of Singapore (SG)
- Queen Mary University of London (GB)
- Royal Stoke University Hospital (GB)
- Shaare Zedek Medical Center (IL)
- University of Manchester (GB)
- San Raffaele University of Rome (IT)
- William Harvey Research Institute (GB)
- NIHR Birmingham Biomedical Research Centre (GB)
- Sotiria General Hospital (GR)
- Keele University (GB)
- University of Split (HR)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1093/ehjopen/oeag030
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00